FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to using a follicle mite extract as an agent for treating or preventing Alzheimer's disease or a mild cognitive disorder. The above extract is prepared by extracting the herbal raw material in an alcohol water solution with the ethanol concentration up to 70%.
EFFECT: invention provides preventing pathological aggregation and protein accumulation accompanying neurodegenerative disorders, as well as dissolving the aggregated protein clumps followed by the removal of degradation products from the brain and organs.
4 cl, 3 tbl, 11 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS FOR TREATMENT OF AMYLOIDOSIS | 2009 |
|
RU2491953C2 |
| DIAGNOSTIC TECHNIQUE FOR AMYLOIDOSIS ACCOMPANYING ALZHEIMER'S DISEASE | 2011 |
|
RU2484471C1 |
| APPLICATION OF THE PIPERAZIN DERIVATIVES FOR TREATMENT OF THE ALZHEIMER'S DISEASE AND THE ALZHEIMER'S TYPE DEMENTIA WITH DISTURBED VENTRICULAR CALCIUM SIGNALING | 2018 |
|
RU2676100C1 |
| METHOD OF AMYLOIDOSIS DIAGNOSTICS IN PATIENTS WITH ALZHEIMERTS DISEASE AND SET OF MEANS FOR ITS REALISATION | 2006 |
|
RU2356058C2 |
| USE OF A BENZOPYRAN DERIVATIVE FOR THE TREATMENT OF DEMENTIA OF ALZHEIMER'S TYPE ASSOCIATED WITH CALCIUM DYSREGULATION | 2023 |
|
RU2804398C1 |
| PEPTIDE AND METHOD OF TREATMENT OF ALZHEIMER'S DISEASE | 2018 |
|
RU2679059C1 |
| APPLICATION OF MIMOTOPES FOR TREATING BETA-AMYLOIDOSES | 2009 |
|
RU2553345C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING DEGENERATIVE BRAIN DISEASE COMPRISING GLYCINE TRANSPORTER AS ACTIVE INGREDIENT | 2021 |
|
RU2816256C1 |
| ANTI-AMYLOID BETA (A BETA) 1-42 MONOCLONAL ANTIBODIES POSSESSING THERAPEUTIC PROPERTIES | 2006 |
|
RU2551782C2 |
| COMPOSITIONS AND METHODS OF TREATING NEUROLOGICAL DISTURBANCES | 2005 |
|
RU2387453C2 |
